We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Kennedy Jr. to lead the U.S. Department of Health and Human Services, which led to over 12% drop in Bio-Techne’s stock prices in the trading sessions from Nov. 14 to Nov. 19. For the current ...
Bio-Techne TECH is making notable strides in its four growth verticals, which are poised to help it grow in the upcoming quarters. The company is now pursuing clinical diagnostic opportunities on ...
TECH Stock Likely to Gain From the Development Since the announcement on Dec. 10, Bio-Techne’s shares dipped 0.4%, closing at $76.81 in yesterday’s session. On a promising note, Bio-Techne ...